PEDIATRICS · 2000 · 93 citations · 32 references
Life SciencesGeneticsMolecular GeneticsGenetic EpidemiologyHuman GeneticsMedical GeneticsGenetic DisordersNeonatal EpidemiologyNeonatal Respiratory DisordersRare Disease GeneticsRespiratory Distress SyndromeAllele FrequencyAmplificationFrameshift MutationsNeonatal Surfactant DeficiencyPediatric Respiratory Distress SyndromePoint EstimatePopulation Frequency AnalysisSurfactant Protein Deficiency
OBJECTIVE: Surfactant protein B deficiency is a lethal cause of respiratory distress in infancy that results most commonly from a homozygous frameshift mutation (121ins2). Using independent clinical ascertainment and molecular methods in different populations, we sought to determine allele frequency. STUDY DESIGN: Using clinical characteristics of the phenotype of affected infants, we screened the Missouri linked birth-death database (n = 1 052 544) to ascertain potentially affected infants. We used molecular amplification and restriction enzyme digestion of DNA samples from a metropolitan New York birth cohort (n = 6599) to estimate allele frequency. RESULTS: The point estimate and 95% confidence interval of the 121ins2 allele frequency in the Missouri cohort are 1/1000 individuals (.03-5.6/1000) and in the New York cohort are.15/1000 (. 08-.25/1000). These estimates are not statistically different. CONCLUSIONS: The close approximation of these independent estimates suggests accurate gene frequency (approximately one 121ins2 mutation per 1000-3000 individuals) despite its rare occurrence and that this mutation does not account for the majority of full-term infants with lethal respiratory distress.
32
World distribution of factor V Leiden
David C. Rees, Michael J. Cox, J. B. Clegg · The Lancet · 1995 · 1.2K citations
J. C. Clark, Susan E. Wert, Cindy J. Bachurski et al. · Proceedings of the National Academy of Sciences · 1995 · 640 citations